HOT TOPICS
Government & Regulation
The End-Stage Renal Disease (ESRD) Program is heavily regulated by the Centers for Medicare & Medicaid Services (CMS), which provides reimbursement to dialysis providers to help pay for the care of kidney disease patients. Kidney-related pharmaceuticals and medical devices are heavily used in dialysis clinics and are also subject to approval and ongoing regulation.
-
Deciphering Meaningful Use Stage 3
Posted in Articles, Government & Regulation
-
NRAA HIE CROWNWeb Submissions 80 Percent Complete
Posted in Articles, Government & Regulation, Practice Management
-
Focus on Finance: Examining the Renal ACO
Posted in Articles, Business, Government & Regulation
-
AAKP, ANNA, Others Recognize Leaders for 113th Congress
Posted in News, Government & Regulation
-
ESRD QIP NHSN Deadline Extended
Posted in Blog, Government & Regulation
-
Kidney Care Leaders Work Toward Kidney Quality
Posted in News, Government & Regulation
-
Immunosuppressive Drug Coverage Introduced, Praised by Dialysis Advocates
Posted in News, Government & Regulation
-
Patients Urge Medicare to Fix HHD Training Reimbursement
Posted in News, Government & Regulation
-
Sequestration Hurting EHR Incentive, CMS Education
Posted in Blog, Government & Regulation
-
AKF, Patient-Advocates Raise Awareness During Capitol Hill Kidney Action Day
Posted in News, Government & Regulation